nPOD honors Estefania Quesada Masachs for type 1 diabetes discoveries
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Instructor Estefania Quesada Masachs, M.D., Ph.D., has won the 2023 Young Investigator
LA JOLLA, CA—La Jolla Institute for Immunology (LJI) Instructor Estefania Quesada Masachs, M.D., Ph.D., has won the 2023 Young Investigator
Dr. Schmiedel is dedicated to shedding light on the genetic mechanisms driving the pathogenesis of human diseases. His research is revealing molecular features regulating immune cell function to enhance our understanding and advance disease diagnosis, treatment, and prevention.
What happened when an LJI scientist revisited a diabetes mystery
No one knows exactly what triggers type 1 diabetes, but researchers at La Jolla Institute for Immunology have uncovered some fascinating clues.
Phase 2 trial run by Novo Nordisk emphasizes the importance of translational research
LA JOLLA—Your pancreas is studded with cell clusters called islets. In most people, special beta cells live snug in the
LA JOLLA—Your pancreas is a little sweet potato-shaped organ that sits snug behind your stomach. The pancreas is studded with
Team: Gustaf Christoffersson The histopathologic features of human type 1 diabetes are remarkably heterogeneous throughout the pancreas. One lobule of
Team: Mehdi Benkahla It is thought that an interaction between predisposing genes and environmental factors, such as viral infections, may
Team: Mehdi Benkahla and Somayeh Sabouri Type 1 diabetes (T1D) is an autoimmune disease characterized by increased blood glucose levels
Team: Sakthi Rajendran, Estefania Quesada-Masachs, Christine Bender Type 1 diabetes (T1D) is an autoimmune disease caused by the destruction of
Team: Sakthi Rajendran, Estefania Quesada-Masachs and Mehdi Benkahla IL-17 is a pro-inflammatory cytokine important in shaping host immune responses against